BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 22722340)

  • 21. Significance of alterations in plasma lipid profile levels in breast cancer.
    Franky Dhaval Shah ; Shilin Nandubhai Shukla ; Pankaj Manubhai Shah ; Patel HR; Prabhudas Shankerbhai Patel
    Integr Cancer Ther; 2008 Mar; 7(1):33-41. PubMed ID: 18292593
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum lipid and lipoprotein profile abnormality in predicting the risk of coronary artery disease in non-diabetic patients attending NMCTH, Birgunj.
    Adak M; Shivapuri JN
    Nepal Med Coll J; 2010 Sep; 12(3):158-64. PubMed ID: 21446364
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatitis B and C coinfections and persistent hepatitis B infections: clinical outcome and liver pathology after transplantation.
    Huang EJ; Wright TL; Lake JR; Combs C; Ferrell LD
    Hepatology; 1996 Mar; 23(3):396-404. PubMed ID: 8617417
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum lipid profiles including non-high density lipoprotein cholesterol levels in Turkish school-children.
    Uçar B; Kiliç Z; Dinleyici EC; Colak O; Güneş E
    Anadolu Kardiyol Derg; 2007 Dec; 7(4):415-20. PubMed ID: 18065339
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Significance of dyslipidaemia in patients with heart failure of unexplained aetiology.
    Skwarek M; Bilińska ZT; Mazurkiewicz Ł; Grzybowski J; Kruk M; Kurjata P; Piotrowski W; Ruzyłło W
    Kardiol Pol; 2008 May; 66(5):515-22, discussion 523-4. PubMed ID: 18537059
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatitis C virus-associated hypobetalipoproteinemia is correlated with plasma viral load, steatosis, and liver fibrosis.
    Petit JM; Benichou M; Duvillard L; Jooste V; Bour JB; Minello A; Verges B; Brun JM; Gambert P; Hillon P
    Am J Gastroenterol; 2003 May; 98(5):1150-4. PubMed ID: 12809841
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of cyclosporin A on serum lipids in primary biliary cirrhosis patients.
    Parsons HG; Thirsk JE; Frohlich J; Dias V; Minuk GY
    Clin Invest Med; 1989 Dec; 12(6):386-91. PubMed ID: 2612091
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bone mineral density, serum insulin-like growth factor I, and bone turnover markers in viral cirrhosis.
    Gallego-Rojo FJ; Gonzalez-Calvin JL; Muñoz-Torres M; Mundi JL; Fernandez-Perez R; Rodrigo-Moreno D
    Hepatology; 1998 Sep; 28(3):695-9. PubMed ID: 9731561
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic significance of glycaemic control in patients with HBV and HCV-related cirrhosis and diabetes mellitus.
    Kwon SY; Kim SS; Kwon OS; Kwon KA; Chung MG; Park DK; Kim YS; Koo YS; Kim YK; Choi DJ; Kim JH
    Diabet Med; 2005 Nov; 22(11):1530-5. PubMed ID: 16241918
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lability of serum low-density lipoprotein cholesterol levels during screening in subgroup of Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS) cohort.
    Clearfield MB; Weis SE; Willis JM; Vasenius KA; McConathy WJ
    J Am Osteopath Assoc; 2002 Jul; 102(7):377-84. PubMed ID: 12138952
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characteristics of lipid metabolism under different urinary protein excretion in children with primary nephrotic syndrome.
    Hu P; Lu L; Hu B; Du PF
    Scand J Clin Lab Invest; 2009; 69(6):680-6. PubMed ID: 19468931
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum lipids as an indicator for the alteration of liver function in patients with hepatitis B.
    Arain SQ; Talpur FN; Channa NA; Ali MS; Afridi HI
    Lipids Health Dis; 2018 Mar; 17(1):36. PubMed ID: 29506525
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The efficacy of gemfibrozil therapy for raising high density lipoprotein levels.
    Weis S; Kudchodkar BJ; Clearfield MB; Lacko AG
    Artery; 1992; 19(6):353-66. PubMed ID: 1471924
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epidemiology of hepatocellular carcinoma. Evaluation of viral and other risk factors in a low-endemic area for hepatitis B and C.
    Peters M; Wellek S; Dienes HP; Junginger T; Meyer J; Meyer Zum Büschendfelde KH; Gerken G
    Z Gastroenterol; 1994 Mar; 32(3):146-51. PubMed ID: 8197809
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of diabetes in hepatocellular carcinoma: a case-control study among United States Veterans.
    El-Serag HB; Richardson PA; Everhart JE
    Am J Gastroenterol; 2001 Aug; 96(8):2462-7. PubMed ID: 11513191
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of lipid profiles and lipoprotein a levels in patients with type 2 diabetes mellitus during oral hypoglycemic or insulin therapy.
    Habib SS; Aslam M; Naveed AK; Razi MS
    Saudi Med J; 2006 Feb; 27(2):174-80. PubMed ID: 16501671
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationship between sustained elevation of serum alanine aminotransferase and progression from cirrhosis to hepatocellular carcinoma: comparison in patients with hepatitis B virus- and hepatitis C virus-associated cirrhosis.
    Sato A; Kato Y; Nakata K; Nakao K; Daikoku M; Ishii N; Matsumoto T; Iseki K; Mazume H; Nagataki S
    J Gastroenterol Hepatol; 1996 Oct; 11(10):944-8. PubMed ID: 8912132
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Decrease of hepatic triglyceride lipase levels and increase of cholesteryl ester transfer protein levels in patients with primary biliary cirrhosis: relationship to abnormalities in high-density lipoprotein.
    Hiraoka H; Yamashita S; Matsuzawa Y; Kubo M; Nozaki S; Sakai N; Hirano K; Kawata S; Tarui S
    Hepatology; 1993 Jul; 18(1):103-10. PubMed ID: 8325601
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative analysis of HBV and HCV infection in hepatocellular carcinoma and chronic liver disease--an autopsy based study.
    Vaiphei K; Pal NS; Arora SK
    Indian J Pathol Microbiol; 2006 Jul; 49(3):357-61. PubMed ID: 17001884
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum Lipid Metabolic Derangement is Associated with Disease Progression During Chronic HBV Infection.
    Cao WJ; Wang TT; Gao YF; Wang YQ; Bao T; Zou GZ
    Clin Lab; 2019 Dec; 65(12):. PubMed ID: 31850701
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.